The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-chlorophenyl)-3-[(1-ethyl-1,2,5,6-tetrahydropyridin-3-yl)-methyl]-2-(2-methylphenyl)quinazolin-4(3H)-one ID: ALA243702
PubChem CID: 11684223
Max Phase: Preclinical
Molecular Formula: C29H28ClN3O
Molecular Weight: 470.02
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CCC=C(Cn2c(-c3ccccc3C)nc3ccc(-c4ccc(Cl)cc4)cc3c2=O)C1
Standard InChI: InChI=1S/C29H28ClN3O/c1-3-32-16-6-8-21(18-32)19-33-28(25-9-5-4-7-20(25)2)31-27-15-12-23(17-26(27)29(33)34)22-10-13-24(30)14-11-22/h4-5,7-15,17H,3,6,16,18-19H2,1-2H3
Standard InChI Key: ZFIGUEXPUFIAPG-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
5.4194 -2.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4182 -3.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1331 -3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8495 -3.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8466 -2.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1313 -1.8747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5596 -1.8686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2768 -2.2830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2729 -0.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5559 -1.0473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9888 -1.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9849 -1.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6947 -2.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4087 -1.8732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4086 -1.0470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6982 -0.6377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2726 0.1910 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8406 -0.6362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8391 0.1888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5544 0.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5548 1.4260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8414 1.8410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1259 1.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1238 0.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1228 -0.6342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8353 -1.0506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5491 -0.6384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5491 0.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8295 0.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1186 0.1849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2629 0.6013 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.5646 -3.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2700 1.8372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9837 1.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16 11 1 0
3 4 2 0
9 17 2 0
10 18 1 0
4 5 1 0
19 18 1 0
19 20 1 0
7 10 1 0
8 12 1 0
11 9 1 0
9 10 1 0
2 3 1 0
19 24 2 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
5 6 2 0
15 25 1 0
11 12 2 0
25 26 2 0
6 1 1 0
26 27 1 0
12 13 1 0
27 28 2 0
1 2 2 0
28 29 1 0
13 14 2 0
29 30 2 0
30 25 1 0
5 7 1 0
28 31 1 0
14 15 1 0
4 32 1 0
7 8 2 0
21 33 1 0
15 16 2 0
33 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 470.02Molecular Weight (Monoisotopic): 469.1921AlogP: 6.34#Rotatable Bonds: 5Polar Surface Area: 38.13Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.31CX LogP: 6.29CX LogD: 5.33Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -0.90
References 1. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH.. (2007) Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity., 50 (21): [PMID:17887659 ] [10.1021/jm070071+ ]